platinum has been researched along with Neoplasms, Cystic, Mucinous, and Serous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Čapkun, V; Miše, BP; Šundov, D; Telesmanić, VD; Tomić, S; Vrdoljak, E | 1 |
Bhore, R; Heffernan, TP; Lea, JS; Schorge, JO; Wingo, SN | 1 |
2 other study(ies) available for platinum and Neoplasms, Cystic, Mucinous, and Serous
Article | Year |
---|---|
Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cadherins; Drug Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Multivariate Analysis; Neoplasm Grading; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Platinum; Prognosis; Survival Rate; Treatment Outcome | 2015 |
Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Platinum; Reoperation; Retrospective Studies | 2010 |